Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Alice Boilève

Assistant professor

Institut Gustave Roussy

France

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in France Professors in Epidemiology Epidemiology professors in France

About

Alice Boilève is an Assistant Professor at Institut Gustave Roussy in France. Her research focuses on early-onset pancreatic and biliary tract cancers, as well as the identification of health conditions associated with pancreatic ductal adenocarcinoma. She has also contributed to the field of precision medicine in advanced pancreatic cancer and neuroendocrine neoplasms through various publications.

Articles (13)

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2021

Year:

2021

Year:

2021

Collaborators (3)

Anthony Turpin

Centre Hospitalier Régional Universitaire de Lille

FRANCE

View details

Stefan Michiels

Université Paris-Saclay

FRANCE

View details

Livia Lamartina

Head of Endocrine Oncology Unit

Institut Gustave Roussy

FRANCE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Alice Boilève

Research Interests

Make your next move.

Explore related searches

About

Articles (13)

Correction: Identifying health conditions associated with an increased risk of pancreatic ductal adenocarcinoma at medium term in nationwide electronic health records of primary care physicians

Third-line treatment of biliary tract cancers in a real-life setting

The increasing burden of early-onset pancreatic and biliary tract cancers: a review of risk factors

Identifying health conditions associated with an increased risk of pancreatic ductal adenocarcinoma at medium term in nationwide electronic health records of primary care physicians

Reply

Anti-Epidermal Growth Factor Receptor Therapy in EGFR -Amplified Esophagogastric Cancers: An Underestimated Efficacy

Organoids for Functional Precision Medicine in Advanced Pancreatic Cancer

Codon-specific KRAS mutations predict survival in advanced pancreatic cancer

Molecular profiling and target actionability for precision medicine in neuroendocrine neoplasms: real-world data

Safety of direct oral anticoagulants in patients with advanced solid tumors receiving anti-VEGF agents: a retrospective study

A diffuse pruriginous erythemato-squamous rash

Combination of Mitotane and Locoregional Treatments in Low-volume Metastatic Adrenocortical Carcinoma

Germline BRCA1 Mutation and Prostate Cancer: Be Careful on Causality

Collaborators (3)

Anthony Turpin

Stefan Michiels

Livia Lamartina

Make your next move.